270 related articles for article (PubMed ID: 31325605)
1. Influence of organic anion transporter 1/3 on the pharmacokinetics and renal excretion of ginkgolides and bilobalide.
Yaro P; Nie J; Xu M; Zeng K; He H; Yao J; Wang R; Zeng S
J Ethnopharmacol; 2019 Oct; 243():112098. PubMed ID: 31325605
[TBL] [Abstract][Full Text] [Related]
2. Effects of 1α,25-dihydroxyvitamin D3 , the natural vitamin D receptor ligand, on the pharmacokinetics of cefdinir and cefadroxil, organic anion transporter substrates, in rat.
Kim YC; Kim IB; Noh CK; Quach HP; Yoon IS; Chow ECY; Kim M; Jin HE; Cho KH; Chung SJ; Pang KS; Maeng HJ
J Pharm Sci; 2014 Nov; 103(11):3793-3805. PubMed ID: 25266751
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of bilobalide, ginkgolide A and B after administration of three different Ginkgo biloba L. preparations in humans.
Woelkart K; Feizlmayr E; Dittrich P; Beubler E; Pinl F; Suter A; Bauer R
Phytother Res; 2010 Mar; 24(3):445-50. PubMed ID: 20041430
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetic properties of Bilobalide and Ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761)].
Fourtillan JB; Brisson AM; Girault J; Ingrand I; Decourt JP; Drieu K; Jouenne P; Biber A
Therapie; 1995; 50(2):137-44. PubMed ID: 7631288
[TBL] [Abstract][Full Text] [Related]
5. Human pharmacokinetics of ginkgo terpene lactones and impact of carboxylation in blood on their platelet-activating factor antagonistic activity.
Liu XW; Yang JL; Niu W; Jia WW; Olaleye OE; Wen Q; Duan XN; Huang YH; Wang FQ; Du FF; Zhong CC; Li YF; Xu F; Gao Q; Li L; Li C
Acta Pharmacol Sin; 2018 Dec; 39(12):1935-1946. PubMed ID: 30054600
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of ginkgolides and bilobalide from extracts of ginkgo biloba using GC/MS.
Biber A; Koch E
Planta Med; 1999 Mar; 65(2):192-3. PubMed ID: 10193211
[TBL] [Abstract][Full Text] [Related]
7. Leflunomide increased the renal exposure of acyclovir by inhibiting OAT1/3 and MRP2.
Liao XY; Deng QQ; Han L; Wu ZT; Peng ZL; Xie Y; Wang GJ; Aa JY; Pan GY
Acta Pharmacol Sin; 2020 Jan; 41(1):129-137. PubMed ID: 31341258
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease.
Ahlemeyer B; Krieglstein J
Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S8-14. PubMed ID: 13130383
[TBL] [Abstract][Full Text] [Related]
9. Determination of Ginkgolides A, B, C, J and Bilobalide in Plasma by LC-ESI (-)/MS/MS (QQQ) and its Application to the Pharmacokinetic Study of Ginkgo Biloba Extract in Rats.
Yan-Yan Z; Li-Li G; Guo-Ming S; Rong R; Jing-Zhen T
Drug Res (Stuttg); 2016 Oct; 66(10):520-526. PubMed ID: 27490936
[TBL] [Abstract][Full Text] [Related]
10. A role for the organic anion transporter OAT3 in renal creatinine secretion in mice.
Vallon V; Eraly SA; Rao SR; Gerasimova M; Rose M; Nagle M; Anzai N; Smith T; Sharma K; Nigam SK; Rieg T
Am J Physiol Renal Physiol; 2012 May; 302(10):F1293-9. PubMed ID: 22338083
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Prediction of Human Renal Clearance and Drug-Drug Interactions of Organic Anion Transporter Substrates Using In Vitro Transport Data: A Relative Activity Factor Approach.
Mathialagan S; Piotrowski MA; Tess DA; Feng B; Litchfield J; Varma MV
Drug Metab Dispos; 2017 Apr; 45(4):409-417. PubMed ID: 28179375
[TBL] [Abstract][Full Text] [Related]
12. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
[TBL] [Abstract][Full Text] [Related]
13. Investigation of Endogenous Compounds Applicable to Drug-Drug Interaction Studies Involving the Renal Organic Anion Transporters, OAT1 and OAT3, in Humans.
Tsuruya Y; Kato K; Sano Y; Imamura Y; Maeda K; Kumagai Y; Sugiyama Y; Kusuhara H
Drug Metab Dispos; 2016 Dec; 44(12):1925-1933. PubMed ID: 27638508
[TBL] [Abstract][Full Text] [Related]
14. The potential drug-drug interactions of ginkgolide B mediated by renal transporters.
Qiu Z; Wang L; Dai Y; Ren W; Jiang W; Chen X; Li N
Phytother Res; 2015 May; 29(5):662-7. PubMed ID: 25589475
[TBL] [Abstract][Full Text] [Related]
15. Bezafibrate-mizoribine interaction: Involvement of organic anion transporters OAT1 and OAT3 in rats.
Feng Y; Wang C; Liu Q; Meng Q; Huo X; Liu Z; Sun P; Yang X; Sun H; Qin J; Liu K
Eur J Pharm Sci; 2016 Jan; 81():119-28. PubMed ID: 26474691
[TBL] [Abstract][Full Text] [Related]
16. Distinct role of bilobalide and ginkgolide A in the modulation of rat CYP2B1 and CYP3A23 gene expression by Ginkgo biloba extract in cultured hepatocytes.
Chang TK; Chen J; Teng XW
Drug Metab Dispos; 2006 Feb; 34(2):234-42. PubMed ID: 16258077
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of ginkgolides A, B, C and bilobalide in plasma by LC-MS/MS and its application to the pharmacokinetic study of Ginkgo biloba extract in rats.
Xie J; Ding C; Ge Q; Zhou Z; Zhi X
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Mar; 864(1-2):87-94. PubMed ID: 18295555
[TBL] [Abstract][Full Text] [Related]
18. Human organic anion transporter OAT1 is not responsible for glutathione transport but mediates transport of glutamate derivatives.
Hagos Y; Burckhardt G; Burckhardt BC
Am J Physiol Renal Physiol; 2013 Feb; 304(4):F403-9. PubMed ID: 23255614
[TBL] [Abstract][Full Text] [Related]
19. PEPT1- and OAT1/3-mediated drug-drug interactions between bestatin and cefixime in vivo and in vitro in rats, and in vitro in human.
Wang L; Wang C; Liu Q; Meng Q; Huo X; Sun P; Yang X; Sun H; Zhen Y; Peng J; Ma X; Liu K
Eur J Pharm Sci; 2014 Oct; 63():77-86. PubMed ID: 25016073
[TBL] [Abstract][Full Text] [Related]
20. Organic anion transporters involved in the excretion of bestatin in the kidney.
Zhu Y; Meng Q; Wang C; Liu Q; Sun H; Kaku T; Liu K
Peptides; 2012 Feb; 33(2):265-71. PubMed ID: 22273603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
